1,169 code entries across 838 active EviCore by Evernorth policies that Backwork has recorded as requiring prior authorization. Each policy links to its page and to the payer’s source.
Summary of the payer’s published policy. Not a coverage determination — confirm with EviCore by Evernorth before submitting.
201–250 of 838, by title
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Codes requiring prior authorization |
|---|---|---|
| Eculizumab (Soliris)Effective 02/01/2023 - 01/31/2024 | Feb 1, 2023 |
|
| Eculizumab (Soliris)Effective 03/01/2020 - 03/14/2021 | Mar 1, 2020 |
|
| Eculizumab (Soliris)Effective 03/15/2021 - 01/31/2021 | Mar 15, 2021 |
|
|---|
| Eculizumab (Soliris)Effective 07/01/2019 - 02/29/2020 | Jul 1, 2019 |
|
|---|
| Eculizumab Products (Soliris, Bkemv, Epysqli) | Not recorded |
|---|
| Eculizumab Products (Soliris, Bkemv, Epysqli)Effective 07/01/2025 - 06/30/2026 | Jul 1, 2025 |
|---|
| Edaravone Injection (Radicava)Effective 02/01/2023 - 01/31/2024 | Feb 1, 2023 |
|
|---|
| Edaravone Injection (Radicava)Effective 03/01/2022 - 01/31/2023 | Mar 1, 2022 |
|
|---|
| Edaravone Injection (Radicava)Effective 03/09/2018 - 08/14/2018 | Mar 9, 2018 |
|
|---|
| Edaravone Injection (Radicava)Effective 04/01/2021 - 02/28/2022 | Apr 1, 2021 |
|
|---|
| Edaravone Injection (Radicava)Effective 05/01/2020 - 03/31/2021 | May 1, 2020 |
|
|---|
| Edaravone Injection (Radicava)Effective 08/15/2018 - 05/31/2019 | Aug 15, 2018 |
|
|---|
| Edaravone Intravenous (Radicava, generic) | Oct 1, 2025 |
|
|---|
| Efgartigimod (Vyvgart)Effective 04/01/2022 - 09/30/2022 | Apr 1, 2022 |
|
|---|
| Efgartigimod (Vyvgart)Effective 10/01/2022 - 08/31/2023 | Oct 1, 2022 |
|
|---|
| Efgartigimod alfa products (Vyvgart-Vyvgart Hytrulo)Effective 12/01/2023 - 11/30/2024 | Dec 1, 2023 |
|---|
| Elaprase (idursulfase) | Not recorded |
|
|---|
| Elaprase (idursulfase)Effective 06/01/2024 - 05/31/2025 | Jun 1, 2024 |
|
|---|
| Elaprase (idursulfase)Effective 06/01/2025 - 05/31/2026 | Jun 1, 2025 |
|
|---|
| Elelyso (taliglucerase alfa) | Not recorded |
|
|---|
| Elelyso (taliglucerase alfa)Effective 05/01/2024 - 04/30/2025 | May 1, 2024 |
|
|---|
| Elelyso (taliglucerase alfa)Effective 05/01/2025 - 04/30/2026 | May 1, 2025 |
|
|---|
| Elfabrio (pegunigalsidase alfa intravenous infusion)Effective 07/01/2024 - 06/30/2025 | Jul 1, 2024 |
|
|---|
| Elfabrio (pegunigalsidase alfa) | Not recorded |
|
|---|
| Elfabrio (pegunigalsidase alfa)Effective 07/01/2025 - 06/30/2026 | Jul 1, 2025 |
|
|---|
| Elfabrio (pegunigalsidase)Effective 10/01/2023 - 06/30/2024 | Oct 1, 2023 |
|
|---|
| Elosulfase Alfa (Vimizim)Effective 01/01/2019 - 09/30/2019 | Jan 1, 2019 |
|
|---|
| Elosulfase Alfa (Vimizim)Effective 07/01/2022 - 06/30/2023 | Jul 1, 2022 |
|
|---|
| Elosulfase Alfa (Vimizim)Effective 07/01/2023 - 05/31/2024 | Jul 1, 2023 |
|
|---|
| Elosulfase Alfa (Vimizim)Effective 08/01/2021 - 06/30/2022 | Aug 1, 2021 |
|
|---|
| Elosulfase Alfa (Vimizim)Effective 09/01/2020 - 07/31/2021 | Sep 1, 2020 |
|
|---|
| Enjaymo (sutimlimab-jome) | Nov 1, 2025 |
|
|---|
| Enjaymo (sutimlimab-jome)Effective 11/01/2023 - 10/31/2024 | Nov 1, 2023 |
|
|---|
| Enjaymo (sutimlimab-jome)Effective 11/01/2024 - 10/31/2025 | Nov 1, 2024 |
|
|---|
| Entyvio Intravenous (vedolizumab) | Not recorded |
|
|---|
| Entyvio Intravenous (vedolizumab)Effective 06/01/2024 - 05/31/2025 | Jun 1, 2024 |
|
|---|
| Entyvio Intravenous (vedolizumab)Effective 06/01/2025 - 05/31/2026 | Jun 1, 2025 |
|
|---|
| Epoetin alfa (Epogen, Procrit, Retacrit)Effective 10/01/2022 - 09/30/2023 | Oct 1, 2022 |
|
|---|
| Epoetin alfa (Epogen, Procrit, Retacrit)Effective 11/01/2021 - 09/30/2022 | Nov 1, 2021 |
|
|---|
| Epoetin alfa (Epogen, Procrit)Effective 11/01/2019 - 11/30/2020 | Nov 1, 2019 |
|---|
| Epoetin alfa (Epogen, Procrit)Effective 12/01/2018 - 10/31/2019 | Dec 1, 2018 |
|---|
| Epoetin alfa (Epogen, Procrit)Effective 12/01/2020 - 10/31/2021 | Dec 1, 2020 |
|---|
| Epogen, Procrit, or Retacrit (epoetin alfa) Non-oncologyEffective 10/01/2023 - 09/30/2024 | Oct 1, 2023 |
|
|---|
| Epogen, Procrit, Retacrit (epoetin alfa) Injection Non-oncology | Oct 1, 2025 |
|
|---|
| Epogen, Procrit, Retacrit (epoetin alfa) Injection Non-oncologyEffective 10/01/2024 - 09/30/2025 | Oct 1, 2024 |
|
|---|
| Epogen, Procrit, Retacrit (epoetin alfa) Injection Non-oncologyEffective 10/01/2026 | Not recorded |
|
|---|
| Epoprostenol (Flolan, Veletri)Effective 01/01/2019 - 06/30/2019 | Jan 1, 2019 |
|
|---|
| Epoprostenol (Flolan, Veletri)Effective 04/01/2022 - 03/31/2023 | Apr 1, 2022 |
|
|---|
| Epoprostenol (Flolan, Veletri)Effective 04/01/2023 - 02/29/2024 | Apr 1, 2023 |
|
|---|
| Epoprostenol (Flolan, Veletri)Effective 05/01/2021 - 03/31/2022 | May 1, 2021 |
|
|---|